Effects of chemotherapy on neurocognitive function in children wIth acute lymphoblastic leukemia: A critical review of the literature

Pediatric Blood and Cancer

Volumn 52, Issue 4, 2009, Pages 447-454

  Buizer, Annemieke I ^a   De Sonneville, Leo M J ^a,b   Veerman, Anjo J P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

ALL; Chemotherapy; Cognition; Late effects; Neurotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER RESEARCH; CANCER RISK; CANCER SURVIVOR; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; DRUG MEGADOSE; HUMAN; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; ARTICLE; BRAIN; CHILD; ONSET AGE; RISK FACTOR; SEX DIFFERENCE; SURVIVOR;

AGE OF ONSET; ANTINEOPLASTIC AGENTS; BRAIN; CHILD; COGNITION; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; SEX FACTORS; SURVIVORS;

EID: 62449193931     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21869     Document Type: Review

References (79)

1. Evans AE, Gilbert ES, Zandstra R. The increasing incidence of central nervous system leukemia in children. Cancer 1970;26:404-409.
2. Ochs JJ, Rivera G, Aur RJ, et al. Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia. J Clin Oncol 1985;3:622-626.
3. George SL, Ochs JJ, Mauer AM, et al. The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol 1985;3:776-781.
4. Pui CH, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998;92:411-415.
5. Moss HA, Nannis ED, Poplack DG. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med 1981;71:47-52.
6. Peylan-Ramu N, Poplack DG, et al. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 1978;298:815-818.
7. Brouwers P, Riccardi R, Poplack D, et al. Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). J Clin Neuropsychol 1984;6:325-336.
8. Wells RJ, Foster MB, D'Ercole AJ, et al. The impact of cranial irradiation on the growth of children with acute lymphocytic leukemia. Am J Dis Child 1983;137:37-39.
9. Sklar C, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993;123:59-64.
10. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325:1330-1336.
11. Walter AW, HancockML, Pui CH, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 1998;16:3761-3767.
12. Nesbit ME Jr, Sather HN, Robison LL, et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: Comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group. Lancet 1981;1: 461-466.
13. Arico M, Conter M, Valsecchi MG, et al. Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. Haematologica 2005;90: 1186-1191.
14. Fletcher JM, Copeland DR. Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol 1988;10:495-537.
15. Cousens P, Waters B, Said J, et al. Cognitive effects of cranial irradiation in leukaemia: A survey and meta-analysis. J Child Psychol Psychiatry 1988;29:839-852.
16. Stehbens JA, Kaleita TA, Noll RB, et al. CNS prophylaxis of childhood leukemia: What are the long-term neurological, neuro-psychological, and behavioral effects? Neuropsychol Rev 1991;2: 147-177.
17. Jankovic M, Brouwers P, Valsecchi MG, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. Lancet 1994;344:224-227.
18. Lockwood KA, Bell TS, Colegrove RW. Long-term effects of cranial radiation therapy on attention functioning in survivors of childhood leukemia. J Pediatr Psychol 1999;24:55-66.
19. Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with a moderatelyintensivetreatmentregimeninnon-high-riskchildhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14: 911 - 918.
20. Tubergen DG, Gilchrist GS, O'Brien RT, et al. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: A Childrens Cancer Group report. J Clin Oncol 1993;11:520-526.
21. Nachman J, Sather HN, Cherlow JM, et al. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the Children's Cancer Group. J Clin Oncol 1998;16:920-930.
22. Kamps WA, Bokkerink JP, Hahlen K, et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). Blood 1999;94:1226-1236.
23. 23.Kamps WA, Bokkerink JP, Hakvoort-Cammel FG, et al. BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: Results of DCLSG protocol ALL-8 (1991-1996). Leukemia 2002;16:1099-1111.
24. Sullivan MP, Chen T, Dyment PG, et al. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: A pediatric oncology group study. Blood 1982;60:948-958.
25. Jones B, Freeman AI, Shuster JJ, et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexametha-sone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 1991;19:269-275.
26. Surtees R, Clelland J, Hann I. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lym-phoblastic leukemia: CSF studies. J Clin Oncol 1998;16:1505-1511.
27. Quinn CT, Griener JC, Bottiglieri T, et al. Elevation of homo- cysteine and excitatory amino acid neurotransmitters in the CSP of children who receive methotrexate for the treatment of cancer. Clin Oncol 1997;15:2800-2806.
28. Copeland DR, Fletcher JM, Pfefferbaum-Levine B, et al. Neuro- psychological sequelae of childhood cancer in long-term survivors. Pediatrics 1985;75:745-753.
29. Butler RW, Hill JM, Steinherz PG, et al. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 1994;12:2621-2629.
30. Langer T, Martus P, Ottensmeier H, et al. CNS late-effects after ALL therapy in childhood. Part III: Neuropsychological performance in long-term survivors of childhood ALL: Impairments of concentration, attention, and memory. Med Pediatr Oncol 2002;38: 320-328.
31. Mulhern RK, Wasserman AL, Fairclough D, et al. Memory function in disease-free survivors of childhood acute lymphocytic leukemiagiven CNS prophylaxis withorwithout1,800 cGycranial irradiation. J Clin Oncol 1988;6:315-320.
32. Ochs J, Mulhern R, Fairclough D, et al. Comparison of neuro- psychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study. J Clin Oncol 1991; 9:145-151.
33. Campbell LK, Scaduto M, Sharp W, et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2007;49: 65-73.
34. Peterson CC, Johnson CE, Ramirez LY, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;51:99-104.
35. Moleski M. Neuropsychological, neuroanatomical, and neuro-physiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000;15:603-630.
36. Carey ME, Haut MW, Reminger SL, et al. Reduced frontal white matter volume in long-term childhood leukemia survivors: A voxel-based morphometry study. Am J Neuroradiol 2008;29:792-797.
37. Jansen NC, Kingma A, Schuitema A, et al. Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: A prospective, sibling-controlled study. Eur J Cancer 2006;42:2765-2772.
38. Buizer AI, De Sonneville LM, van den Heuvel-Eibrink MM, et al. Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. J Int Neuropsychol Soc 2005;11:554-565.
39. Buizer AI, de Sonneville LM, van den Heuvel-Eibrink MM, et al. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: Effect of treatment intensity. Pediatr Blood Cancer 2005;45:281-290.
40. Mennes M, Stiers P, Vandenbussche E, et al. Attention and information processing in survivors of childhood acute lympho-blastic leukemia treated with chemotherapy only. Pediatr Blood Cancer 2005;44:479-486.
41. Hill DE, Ciesielski KT, Hart BL, et al. MRI morphometric and neuropsychological correlates of long-term memory in survivors of childhood leukemia. Pediatc Blood Cancer 2004;42:611-617.
42. Schatz J, Kramer JH, Ablin AR, et al. Visual attention in long-term survivors of leukemia receiving cranial radiation therapy. J Int Neuropsychol Soc 2004;10:211-220.
43. Kaemingk KL, Carey ME, Moore IM, et al. Math weaknesses in survivors of acute lymphoblastic leukemia compared to healthy children. Child Neuropsychol 2004;10:14-23.
44. Von der Weid N, Mosimann I, Hirt A, et al. Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: Age- and sex-related differences. Eur J Cancer 2003;39:359-365.
45. Rodgers J, Marckus R, Kearns P, et al. Attentional ability among survivors of leukaemia treated without cranial irradiation. Arch Dis Child 2003;88:147-150.
46. Kingma A, Van Dommelen RI, Mooyaart EL, et al. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: A prospective longitudinal study. J Pediatr Hematol Oncol 2002;24:106-114.
47. PrecourtS,Robaey P, Lamothe I, et al. Verbal cognitive functioning and learning in girls treated for acute lymphoblastic leukemia by chemotherapy with or without cranial irradiation. Dev Neuro-psychol 2002;21:173-195.
48. Kingma A, Van Dommelen RI, Mooyaart EL, et al. Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr 2001;139:413-420.
49. Lahteenmaki PM, Holopainen I, Krause CM, et al. Cognitive functions of adolescent childhood cancer survivors assessed by event-related potentials. Med Pediatr Oncol 2001;36:442-450.
50. Anderson VA, Godber T, Smibert E, et al. Cognitive and academic outcome following cranial irradiation and chemotherapy in children: A longitudinal study. Br J Cancer 2000;82:255-262.
51. Raymond-Speden E, Tripp G, Lawrence B, et al. Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. J Pediatr Psychol 2000;25:59-68.
52. Schatz J, Kramer JH, Ablin A, et al. Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 2000;14: 189-200.
53. Brown RT, Sawyer MG, Antoniou G, et al. Longitudinal follow-up of the intellectual and academic functioning of children receiving central nervous system-prophylactic chemotherapy for leukemia: A four-year final report. J Dev Behav Pediatr 1999;20:373-377.
54. Lesnik PG, Ciesielski KT, Hart BL, et al. Evidence for cerebellar- frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia-Enhanced data analysis using an effect size model. Arch Neurol 1998;55:1561-1568.
55. Anderson V, Godber T, Smibert E, et al. Neurobehavioural sequelae following cranial irradiation and chemotherapy in children: An analysis of risk factors. Pediatr Rehabil 1997;1:63-76.
56. Dongen-Melman JE, De Groot A, Van Dongen JJ, et al. Cranial irradiation is the major cause of learning problems in children treated for leukemia and lymphoma: A comparative study. Leukemia 1997;11:1197-1200.
57. Eiser C. Cognitive deficits in children treated for leukaemia. Arch Dis Child 1991;66:164-168.
58. Buizer AI, De Sonneville LM, van den Heuvel-Eibrink MM, et al. Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. Cancer 2006;106:2067-2075.
59. Ciesielski KT, Lesnik PG, Benzel EC, et al. MRI morphometry of mamillary bodies, caudate nuclei, and prefrontal cortices after chemotherapy for childhood leukemia: Multivariate models of early and late developing memory subsystems. Behav Neurosci 1999;113:439-450.
60. De Bellis MD, Keshavan MS, Beers SR, et al. Sex differences in brain maturation during childhood and adolescence. Cerebral Cortex 2001;11:552-557.
61. Waber DP, Tarbell NJ, Kahn CM, et al. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol 1992;10:810-817.
62. Jannoun L. Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukaemia? Arch Dis Child 1983;58:953-958.
63. Brown RT, Madan-Swain A, Pais R, et al. Chemotherapy for acute lymphocytic leukemia: Cognitive and academic sequelae. J Pediatr 1992;121:885-889.
64. Giralt J, Ortega JJ, Olive T, et al. Long-term neuropsychologic sequelae of childhood leukemia: Comparison of two CNS prophylactic regimens. Int J Radiat Oncol Biol Phys 1992;24: 49-53.
65. Schlieper AE, Esseltine DW, Tarshis E. Cognitive function in long survivors of childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1989;6:1 -9.
66. Lansky SB, Cairns NU, Lansky LL, et al. Central nervous system prophylaxis. Studies showing impairment in verbal skills and academic achievement. Am J Pediatr Hematol Oncol 1984;6:183-190.
67. Butler RW, Copeland DR. Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 2002;8:115-124.
68. Butler RW. Attentional processes and their remediation in childhood cancer. Med Pediatr Oncol 1998; Suppl 1:75-78.
69. Butler RW, Copeland DR, Fairclough L, et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008;76:367-378.
70. Mulhern RK, Khan RB, Kaplan S, et al. Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. Clin Oncol 2004;22: 4743-4751.
71. Ball WSJ, Prenger EC, Ballard ET. Neurotoxicity of radio/chemotherapy in children: Pathologic and MR correlation. Am J Neuroradiol 1992;13:761-776.
72. Vezmar S, Becker A, Bode U,etal. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003;49: 92-104.
73. Kahkonen M, Harila-Saari A, Metsahonkala L, et al. Cerebral blood flow and glucose metabolism in long-term survivors of childhood acute lymphoblastic leukaemia. Eur J Cancer 1999;35: 1102-1108.
74. Chu WC, Chik KW, Chan YL, et al. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: Longitudinal study with MR imaging and 1H MR spectroscopy. Radiology 2003;229:659-669.
75. Paakko E, Harila-Saari A, Vanionpaa L, et al. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: Correlation with neuropsychological findings. Med Pediatr Oncol 2000;35:456-461.
76. Wilson DA, Nitschke R, Bowman ME, et al. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: Correlation with neuropsychologic deficiencies. Radiology 1991;180:205-209.
77. Seidel H, Nygaard R, Haave I, et al. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children. Acta Paediatr 1996;85:450-453.
78. Khong PL, Leung LH, Fung AS, et al. White matter anisotropy in post-treatment childhood cancer survivors: Preliminary evidence of association with neurocognitive function. J Clin Oncol 2006;24: 884-890.
79. Zou P, Mulhern RK, Butler RW, et al. BOLD responses to visual stimulation in survivors of childhood cancer. Neuroimage 2005; 24:61-69.